netFormulary NHS
North Staffordshire Joint Formulary
North Staffordshire Clinical Commissioning Group
Stoke-on-Trent Clinical Commissioning Group
 Search
 Results

Looking for Atezolizumab found 9 matches

Open monograph to display formulary status BNF Category
  Cytotoxic Drug Atezolizumab  (Tecentriq) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 
Non Formulary BNF Category
  Atezolizumab
(EAMS)
Unlicensed Medicines / Significant off-label use - Unlicensed Medicines - 20


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA492: Atezolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (08.01.05)
link in drug section NICE TA520 : Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy (08.01.05)
link in drug section NICE TA525: Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy (08.01.05)
link in drug section NICE TA584: Atezolizumab in combination for treating metastice non-squamous non-small-cell lung cancer (08.01.05)
link in drug section NICE TA638: Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer (08.01.05)
link in drug section NICE TA639: Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer (08.01.05)
link in drug section NICE TA666: Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma (08.01.05)


 

netFormulary